Since pharma'ps big wave of innovation during the early 1990s, peaking in 1996 when 131 new drug applications were filed …
Vaccine companies are to compete with each other to produce a vaccine against a potential pandemic flu – although no-one …
Competition in one of the industry's fastest growing markets is intensifying with new approvals for two TNF-blocker drugs.Schering-Plough and Centocor's …
Healthcare agency Resolute Communications has been named consultancy of the year at the PRWeek awards, believed to be the first …
The world's first-ever contraceptive pill to offer women complete freedom from menstruation could be launched by next year.Wyeth's Lybrel is …
Early results from trials suggest adding Tarceva to Avastin has no extra benefit in the treatment of kidney cancer.Researchers at …
The government sees choice as a major driver for promoting quality, responsiveness, efficiency and equity in public services. Choice in …
Merck is to develop a new monoclonal antibody which has shown promise in treating prostate cancer.The US company has signed …
Exubera, the first ever inhaled insulin product is set for approval in Europe following a key regulatory recommendation.The positive opinion …
The new onus on outsourcing has seen CROs reap the benefits of an industry striving to cut resource investment while …
Pharmaceutical companies are being urged to step up vaccine production as the strain of bird flu that killed 59 people …
Pfizer has won an important legal battle to maintain its UK patent on best-selling cholesterol drug Lipitor.The UK High Court …
Apidra, a new short-acting insulin analogue, has been launched in the UK by Sanofi-Aventis.Short-acting analogues have a faster onset of …
Europe's medicines regulator is looking to communicate more effectively with pharma companies as part of a drive to accelerate drug …
Merck looks set to launch a new public relations campaign across Europe in an attempt to repair damage done to …
The government lost the vote at its party conference on expanding the role of the private sector in the NHS.A …
A significant minority of shareholders in VNU are against its planned $7 billion acquisition of pharmaceutical information company IMS Health.The …
Following an eight-week period of public consultation, the Committee on Safety of Medicines is to shortly advise health ministers about …
Novartis has awarded advertising accounts for its ophthalmology and transplantation portfolios to Manchester-based advertising agency Creative Lynx.The pharma company held …
GPs are calling out for pharmaceutical companies to provide them with management skills as they take on a new role …